Preliminary characterization of the role of protein serine/ threonine phosphatases in the regulation of human lung mast cell function

Peirce, M.J., Cox, S.E., Munday, M. and Peachell, P.T. (1997) Preliminary characterization of the role of protein serine/ threonine phosphatases in the regulation of human lung mast cell function. British Journal of Pharmacology, 120 (2). pp. 239-246. 10.1038/sj.bjp.0700915.

Full text not available from this repository.

DOI: 10.1038/sj.bjp.0700915

Abstract

Okadaic acid, a cell permeant inhibitor of protein serine/threonine phosphatases (PPs), attenuated the IgE-dependent release of mediators from human lung mast cells (HLMC). The concentration of okadaic acid required to inhibit by 50% (IC50) the IgE-dependent release of histamine was 0.2 μM. Okadaic acid also inhibited the IgE-mediated generation of prostaglandin D2 (PGD2) and sulphopeptidoleukotrienes (sLT) with IC50 values of 0.2 μM and 0.6 μM respectively. 2. The IgE-mediated generation of histamine, PGD2 and sLT was inhibited by okadaic acid and two analogues of okadaic acid, okadaol and okadaone, with the following rank order of activity; okadaic acid > okadaol > okadaone. This order of activity for the inhibition of mediator release parallels the activity of these compounds as inhibitors of isolated PPs. 3. Extracts of HLMC liberated 32P from radiolabelled glycogen phosphorylase and this PP activity was inhibited by the PP inhibitors (all at 3 μM), okadaic acid (73 ± 4% inhibition, P < 0.0005), okadaol (26 ± 7% inhibition, P < 0.05) and okadaone (8 ± 7% inhibition, P = 0.52). The rank order of activity of okadaic acid > okadaol > okadaone parallels the activity of these compounds as inhibitors of isolated PPs. 4. Dephosphorylation of radiolabelled glycogen phosphorylase by extracts of HLMC was inhibited by 15 ± 3% (P < 0.001) by a low (2 nM) concentration of okadaic acid and by 88 ± 4% (P < 0.0005) by a higher (5 μM) concentration of okadaic acid. Because 2 nM okadaic acid may act selectively to inhibit PP2A whereas 5 μM okadaic acid inhibits both PP1 and PP2A, these data suggest that both PP1 and PP2A are present in HLMC. 5. Inhibitor 2, a PP1-selective inhibitor, attenuated (71 ± 3% inhibition, P < 0.05) PP activity in extracts of HLMC suggesting that HLMC contain PP1 and that it may constitute 71% of the phosphorylase PP activity in extracts of HLMC. 6. Radiolabelled casein, a PP2A-restricted substrate, was dephosphorylated by extracts of purified HLMC and this activity was inhibited (81 ± 8% inhibition, P < 0.005) by 2 nM okadaic acid suggesting that PP2A is resident in HLMC. 7. Collectively, these data suggest that both PP1 and PP2A are resident in HLMC. However, although the data suggest that okadaic acid regulates responses in HLMC by interacting with PPs, it has not been possible to determine whether either PP1 or PP2A or both PPs are involved in the okadaic acid-induced inhibition of mediator release from HLMC.

Item Type:Article
Uncontrolled Keywords:Dephosphorylation; Mast cells; Mediator release; Okadaic acid; Phosphatases
Departments, units and centres:Department of Pharmaceutical and Biological Chemistry > Department of Pharmaceutical and Biological Chemistry
ID Code:3013
Journal or Publication Title:British Journal of Pharmacology
Deposited By:Library Staff
Deposited On:22 Mar 2012 11:30
Last Modified:22 Mar 2012 11:30

Repository Staff Only: Item control page

School of Pharmacy Staff Only: Edit a copy to replace this item